Kathy Boxall

2.5k citations

20 papers · 821 indexed · h-index 15

Molecular Biology
Oncology
Computational Theory and Mathematics top 5%
Organic Chemistry top 10%
Cell Biology top 10%

Co-authors: G. Wynne Aherne Ian Collins Paul Workman Swee Y. Sharp Michelle D. Garrett Swen Hoelder Richard Bayliss Florence I. Raynaud
Topics: Cancer-related Molecular Pathways (6 papers)Microtubule and mitosis dynamics (6 papers)DNA Repair Mechanisms (5 papers)
Cited by: Computational Theory and Mathematics Cell Biology Molecular Biology
Journals: PLoS ONE Cancer Research Clinical Cancer Research
Partner nations: United Kingdom United States Australia

In The Last Decade

Kathy Boxall

20 papers receiving 812 citations

Peers

Countries citing papers authored by Kathy Boxall

Since Specialization

Citations

This map shows the geographic impact of Kathy Boxall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Boxall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Boxall more than expected).

Fields of papers citing papers by Kathy Boxall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Boxall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Boxall. The network helps show where Kathy Boxall may publish in the future.

Co-authorship network of co-authors of Kathy Boxall

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Boxall. A scholar is included among the top collaborators of Kathy Boxall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Boxall. Kathy Boxall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase 2020 ·RSC Medicinal Chemistry ·Christopher J. Matheson,Christopher R. Coxon,Richard Bayliss,Kathy Boxall,Benoît Carbain,Andrew M. Fry,Ian R. Hardcastle,Suzannah J. Harnor,Corine Mas-Droux,David R. Newell,Mark W. Richards,(unknown),David M. Turner,Roger J. Griffin,Bernard T. Golding,Céline Cano	14
2	Structure-guided design of purine-based probes for selective Nek2 inhibition 2016 ·Oncotarget ·Christopher R. Coxon,Christopher Wong,Richard Bayliss,Kathy Boxall,(unknown),Andrew M. Fry,Ian R. Hardcastle,Christopher J. Matheson,David R. Newell,(unknown),Huw D. Thomas,David M. Turner,Sharon Yeoh,Lan Z. Wang,Roger J. Griffin,Bernard T. Golding,Céline Cano	12
3	Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance 2015 ·Cancer Research ·Mark D. Gurden,Isaac M. Westwood,Amir Faisal,Sébastien Naud,Kwai-Ming J. Cheung,Craig McAndrew,Amy Wood,(unknown),Kathy Boxall,Grace Wing-Yan Mak,Paul Workman,Rosemary Burke,Swen Hoelder,Julian Blagg,Rob L. M. van Montfort,Spiros Linardopoulos	24
4	Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2 2013 ·PLoS ONE ·(unknown),Isaac M. Westwood,Kathy Boxall,Nathan Brown,(unknown),Craig McAndrew,(unknown),(unknown),Amin Mirza,Antony W. Oliver,Rosemary Burke,Swen Hoelder,Keith Jones,G. Wynne Aherne,Julian Blagg,Ian Collins,Michelle D. Garrett,Rob L. M. van Montfort	12
5	The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design 2013 ·Oncotarget ·S. Couty,Isaac M. Westwood,Andrew Kalusa,Céline Cano,Jon Travers,Kathy Boxall,(unknown),(unknown),(unknown),Lisa Pickard,Caterina Barillari,Craig McAndrew,Paul A. Clarke,Spiros Linardopoulos,Roger J. Griffin,G. Wynne Aherne,Florence I. Raynaud,Paul Workman,Keith Jones,Rob L. M. van Montfort	17
6	CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs 2012 ·Clinical Cancer Research ·Mike I. Walton,Paul D. Eve,Angela Hayes,Melanie Valenti,Alexis K. de Haven Brandon,Gary Box,Albert Hallsworth,(unknown),Kathy Boxall,Michael Lainchbury,Thomas P. Matthews,Yann Jamin,Simon P. Robinson,G. Wynne Aherne,John Reader,Louis Chesler,Florence I. Raynaud,Suzanne A. Eccles,Ian Collins,Michelle D. Garrett	69
7	Design of Potent and Selective Hybrid Inhibitors of the Mitotic Kinase Nek2: Structure–Activity Relationship, Structural Biology, and Cellular Activity 2012 ·Journal of Medicinal Chemistry ·Paolo Innocenti,Kwai-Ming J. Cheung,(unknown),Corine Mas-Droux,(unknown),Sharon Yeoh,Kathy Boxall,(unknown),Lisa Pickard,Tara Hardy,Joanne E. Baxter,G. Wynne Aherne,Richard Bayliss,Andrew M. Fry,Swen Hoelder	56
8	Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors 2012 ·Journal of Medicinal Chemistry ·Michael Lainchbury,Thomas P. Matthews,Tatiana McHardy,Kathy Boxall,Michael I. Walton,Paul D. Eve,Angela Hayes,Melanie Valenti,Alexis K. de Haven Brandon,Gary Box,G. Wynne Aherne,John Reader,Florence I. Raynaud,Suzanne A. Eccles,Michelle D. Garrett,Ian Collins	22
9	Benzimidazole Inhibitors Induce a DFG-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure−Activity Relationship 2011 ·Journal of Medicinal Chemistry ·(unknown),Paolo Innocenti,Corine Mas-Droux,Kathy Boxall,Caterina Barillari,Rob L. M. van Montfort,G. Wynne Aherne,Richard Bayliss,Swen Hoelder	43
10	The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106 2010 ·Molecular Cancer Therapeutics ·Michael I. Walton,Paul D. Eve,Angela Hayes,Melanie Valenti,Alexis de Haven Brandon,Gary Box,Kathy Boxall,G. Wynne Aherne,Suzanne A. Eccles,Florence I. Raynaud,D. H. Williams,John Reader,Ian Collins,Michelle D. Garrett	63
11	Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases 2010 ·Bioorganic & Medicinal Chemistry Letters ·Thomas P. Matthews,Tatiana McHardy,(unknown),Kathy Boxall,Martin Fisher,(unknown),(unknown),(unknown),(unknown),G. Wynne Aherne,Isaac M. Westwood,Rob van Montfort,Michelle D. Garrett,John Reader,Ian Collins	20
12	Structure-Based Design of Potent and Selective 2-(Quinazolin-2-yl)phenol Inhibitors of Checkpoint Kinase 2 2010 ·Journal of Medicinal Chemistry ·John Caldwell,E. Jane Welsh,(unknown),Victoria E. Anderson,Laurent Antoni,Kathy Boxall,Frederique Urban,Angela Hayes,Florence I. Raynaud,Laurent Rigoreau,Tony Raynham,G. Wynne Aherne,Laurence H. Pearl,Antony W. Oliver,Michelle D. Garrett,Ian Collins	42
13	Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization 2010 ·Journal of Medicinal Chemistry ·Daniel K. Whelligan,(unknown),Dawn Taylor,Douglas W. Thomson,Kwai-Ming J. Cheung,Kathy Boxall,Corine Mas-Droux,Caterina Barillari,(unknown),(unknown),Ian Collins,Rob L. M. van Montfort,G. Wynne Aherne,Richard Bayliss,Swen Hoelder	56
14	Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening 2009 ·Journal of Medicinal Chemistry ·Thomas P. Matthews,(unknown),(unknown),Kathy Boxall,(unknown),Martin Fisher,Isaac M. Westwood,Michael I. Walton,Tatiana McHardy,Kwai-Ming J. Cheung,Rob van Montfort,David J. Williams,G. Wynne Aherne,Michelle D. Garrett,John Reader,Ian Collins	35
15	Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2 2009 ·Bioorganic & Medicinal Chemistry ·Stephen T. Hilton,Sébastien Naud,John Caldwell,Kathy Boxall,(unknown),Victoria E. Anderson,Laurent Antoni,(unknown),Laurence H. Pearl,Antony W. Oliver,G. Wynne Aherne,Michelle D. Garrett,Ian Collins	48
16	Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin 2007 ·Organic & Biomolecular Chemistry ·Christopher S. P. McErlean,(unknown),Christopher J. Davis,(unknown),Swee Y. Sharp,Kathy Boxall,Alexandra M. Z. Slawin,Paul Workman,Christopher J. Moody	16
17	Inhibition of Hsp90 with Synthetic Macrolactones: Synthesis and Structural and Biological Evaluation of Ring and Conformational Analogs of Radicicol 2006 ·Chemistry & Biology ·(unknown),Swee Y. Sharp,Kathy Boxall,Stephen Connelly,S. Mark Roe,Chrisostomos Prodromou,Alexandra M. Z. Slawin,Laurence H. Pearl,Paul Workman,Christopher J. Moody	53
18	Solid-Phase Immunoassays in Mechanism-Based Drug Discovery: Their Application in the Development of Inhibitors of the Molecular Chaperone Heat-Shock Protein 90 2005 ·Assay and Drug Development Technologies ·Anthea Hardcastle,Kathy Boxall,(unknown),P J Tomlin,Swee Y. Sharp,Paul A. Clarke,Paul Workman,Wynne Aherne	8
19	Mechanism of action of a novel series of inhibitors of the Hsp90 molecular chaperone 2004 ·Cancer Research ·Swee Y. Sharp,Alison Maloney,Paul A. Clarke,Wynne Aherne,Suzanne A. Eccles,Kathy Boxall,Martin Rowlands,Florence I. Raynaud,Bernard Nutley,Nicola F. Smith,Angela Hayes,Anthea Hardcastle,Laurence H. Pearl,(unknown),(unknown),(unknown),Thomas P. Matthews,(unknown),Martin J. Drysdale,Paul Workman	1
20	Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms 2004 ·Chemistry & Biology ·Lisa Wright,Xavier Barril,Brian Dymock,(unknown),A.E. Surgenor,Mandy Beswick,Martin J. Drysdale,Adam J. Collier,Andy Massey,Nicholas G. Davies,(unknown),Christophe Fromont,Wynne Aherne,Kathy Boxall,Swee Y. Sharp,Paul Workman,Roderick E. Hubbard	210

About Kathy Boxall

Kathy Boxall is a scholar working on Cell Biology, Oncology and Molecular Biology, having authored 20 papers that have together received 821 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Microtubule and mitosis dynamics (6 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Computational Theory and Mathematics (172 citations), Cell Biology (157 citations) and Molecular Biology (660 citations). Kathy Boxall has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include G. Wynne Aherne, Ian Collins, Paul Workman, Swee Y. Sharp, Michelle D. Garrett, Swen Hoelder, Richard Bayliss, Florence I. Raynaud, Corine Mas-Droux and John Reader. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact